Biofocus has announced that it will provide compound management services to the National Cancer Institute (NCI).
Biofocus runs a compound management facility for a number of industrial and US government customers out of its Compound Focus subsidiary in south San Francisco.
Under this agreement, Compound Focus will establish a Small Molecule Repository for the NCI Chemical Biology Consortium (CBC).
This repository will form part of the CBC's drug discovery and development platform for new oncology therapeutics being researched by a consortium of primarily academic institutions.
